Navigation Links
Novus Scientific & Surgical Momentum Partner for Continuous Quality Improvement Program (CQI)
Date:2/21/2012

SINGAPORE, Feb. 21, 2012 /PRNewswire/ -- Novus Scientific today announced an agreement between its CEO Thomas Engstrom, and Thomas Lennon, Jr., CEO of Surgical Momentum LLC, starting an exciting working relationship involving a new breed of surgical mesh - TIGR® Matrix Surgical Mesh.

The Novus Scientific and Surgical Momentum teams have worked together to design a continuous quality improvement (CQI) program that will analyze the use of TIGR® Matrix for the reinforcement of soft tissue where weakness exists. The teams will define the clinical processes, size of the patient population, outcomes measured and determine the clinical site(s) for the project. The initial phase of the study is expected to last for a period of at least one year.

It became clear in early discussions between Novus and Surgical Momentum that their goals were aligned, making partnership a very compelling possibility. Novus Scientific is the very first surgical mesh product manufacturer to sign an agreement with Surgical Momentum. The agreement's defining objective is "the identification and conversion of clinical need into life-improving applications and devices that improve patient care."

"This agreement between Novus Scientific and Surgical Momentum could not have come at a more exciting time in the lifecycle of TIGR® Matrix," said Thomas Engstrom, CEO of Novus Scientific. "We have already gained a huge amount of insight into the potential of TIGR® Matrix thanks to Surgical Momentum's encouragement, and we look forward to receiving the data that emerges from the CQI program and converting it into pure benefit for patients and clinicians in the future."

Surgical Momentum's goal is to improve patient outcomes by addressing the inherent complexity of patient care. It uses an innovative Clinical Continuous Quality Improvement process to support, analyze and improve care. By replacing hierarchical, antiquated systems and protocols with real-time adaptive processes and new roles that emphasize better communication and coordination between all stakeholders, Surgical Momentum has seen dramatic improvements in clinical results.

Dr. Bruce Ramshaw, one of the founders of Surgical Momentum and its Chief Medical Officer, stated: "I believe that industrial revolution organization, structures and work models will not allow for individual autonomy, mastery and purpose for our health care workforce, no matter what technology or tools are developed. We have moved beyond the information age to the age of networks and relationships. Our model for patient care is a direct reflection of this belief."

TIGR® Matrix Surgical Mesh is available for sale in the U.S. and selected countries in Europe and Asia.

About Novus Scientific
Novus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of resorbable synthetic medical devices.
Visit our PRESSROOMhttp://www.mynewsdesk.com/pressroom/novus-scientific or follow on Twitter: NovusScientific.

About Surgical Momentum
Surgical Momentum was formed to apply complexity science principles to improve health care. It utilizes innovative models, such as patient-centered care and Continuous Quality Improvement, to deliver better patient outcomes, better products, and lower overall costs of care. To learn more about this study and Surgical Momentum, visit us at: http://MomentumResearch.org/Novus

TIGR® is a trademark of Novus Scientific Pte. Ltd  086M-01

CONTACT:  Jim Archetto: Cell - 508-769-5902 / Toll Free - 877-211-4337 - jim.archetto@novusscientific.com


'/>"/>
SOURCE Novus Scientific
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Novus Scientific Receives FDA Clearance for TIGR(TM) Matrix Surgical Mesh - Worlds 1st Long-Term Resorbable Synthetic Mesh
2. Novus Scientific Announces the Sales Launch for TIGR™ Matrix Surgical Mesh - Worlds 1st Long-Term Resorbable Synthetic Mesh
3. Novus Scientific and Singapore Association of Plastic Surgeons (SAPS) Host the Inaugural Event of SOFTISSUE - The Issue of Soft Tissue, Featuring James J. Chao, M.D., FACS, Professor of Plastic Surgery and Orthopedic Surgery, University of Califor
4. Novus Scientific Announces the Worlds 1st Long-Term Absorbable Mesh as an Alternative to Non-Absorbable Synthetic Mesh
5. Novus Scientific Announces a New U.S. Patent for a Mesh Implant Comprising Two Different Resorbable Materials with Different Degradation Times and Specific Mechanical Behaviours; U.S. Patent No. -- 8,083,755
6. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
7. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
8. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
9. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
10. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
11. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016 /PRNewswire/ ... pulmonary function testing company, is now able to perform sophisticated lung ... ndd Medical Technologies , Inc. Patients are ... labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients like ... any needed testing done in the comfort of her own home. ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... startling report released today, National Safety Council research shows ... plan to eliminate prescription opioid overdoses. Prescription Nation ... the worst drug crisis in recorded U.S. history, assigned a "Making ... , New Mexico , Tennessee ... states, three – Michigan , Missouri ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from PsychTests.com reveals that behind the tendency to ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing ... which patients and their families pay tribute to a genetic counselor by nominating him ... Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome ...
(Date:6/24/2016)... ... ... recruitment firm Slone Partners is pleased to announce the placement of Suzanne ... of North American Capital Sales at HTG Molecular . , In ... commercialization of the HTG EdgeSeq system and associated reagents in North America. , Headquartered ...
Breaking Medicine News(10 mins):